Objectives-To examine whether the activities of creatine kinase (CK) correlate with neurological disturbances caused by acrylamide. Methods-The activities of CK and other enzymes reported to be inhibited by acrylamide in the brain and plasma, and landing foot spread (LFS) were measured in mice and rats intoxicated with acrylamide. To explore the involvement of brain CK in the genesis of neurotoxicity of acrylamide, we examined whether activities of CK in the brain correlate with the neurological disturbances in mice given acrylamide, along with other enzyme activities which have been reported to be inhibited by acrylamide.3 If a clear correlation between activities of CK in the brain and neurological deficits is found, it seems interesting to examine whether activity of CK in the blood, which is measured frequently in the blood chemistry, can be a peripheral marker of acrylamide intoxication. In the second experiment with rats, we therefore measured the activities of CK in the plasma.
Acrylamide is a potent neurotoxin which can cause neuropathy and encephalopathy in humans and in animals.' 2 Although inhibition of several enzyme activities by acrylamide have been found,2 and postulated as the possible pathogenesis of its neurotoxicity, the mechanism of toxicity of acrylamide has not been clarified. We have found that acrylamide inhibits creatine kinase (CK, enzyme commission number (EC) 2-7-3 2) activities in the rat brain.67 Creatine kinase is present in neurons, astrocytes, and oligodendrocytes,8 and seems to play an important part in continuously replenishing ATP from phosphocreatine in these cells,9 catalysing the reaction:
phosphocreatine + ADP *-+. ATP + creatine.
To explore the involvement of brain CK in the genesis of neurotoxicity of acrylamide, we examined whether activities of CK in the brain correlate with the neurological disturbances in mice given acrylamide, along with other enzyme activities which have been reported to be inhibited by acrylamide. 3 If a clear correlation between activities of CK in the brain and neurological deficits is found, it seems interesting to examine whether activity of CK in the blood, which is measured frequently in the blood chemistry, can be a peripheral marker of acrylamide intoxication. In the second experiment with rats, we therefore measured the activities of CK in the plasma.
Method FIRST EXPERIMENT
Male ddy mice weighing 26-30 g were obtained from Kyudo (Kumamoto, Japan). Animals had free access to food and water throughout the experimental period. Acrylamide was dissolved in 0-85% NaCl and injected intraperitoneally (50 mg/kg/day) from day 0 to 7 (total dose; 400 mg/kg). After eight injections, all mice were allowed to recover from day 8 to 50. Animals given acrylamide were killed on days 5, 8, 11, 15, 23, 36, and 50. Two control groups were prepared as follows. On day 0, mice without any injections were killed by decapitation (control 1). As the experiments were done over 51 days, mice given isotonic saline (2.0 ml/100 g/day) from day 0 to 7 were killed on day 50 (control 2) to evaluate possible effects of aging. After decapitation, the forebrain was removed and kept at -40'C until use.
The body weight was measured every day and the behaviours of each mouse were carefully observed. To evaluate the neurological deficit, the distance between toe pads of bilateral hind limbs was measured when the mouse landed from the height of 30 cm (landing foot spread, LFS).'0 This measurement was performed before each injection (day 0-7) and on appropriate days during the recovery with eight (five on day 50) mice which were selected randomly each day.
Frozen tissues were thawed at room temperature for 20 minutes. Subsequent procedures were all carried out at 0-40C. Each tissue was homogenised in five volumes of ice cold 50 mM sodium phosphate buffer, pH 7.4 containing 1 mM EDTA and 1 mM dithiothreitol, with an all glass Potter-Elvehjem homogeniser. Part of the homogenates (350 gl) was centrifuged at 1200 g for 10 minutes and supernatants without nuclei were obtained. Remaining homogenates were centrifuged at 15 000 g for 10 minutes, and the resulting supernatants were further centrifuged at 100 000 g for 60 minutes to obtain the soluble fractions. These supernatants were kept at -120'C until analysis. The super-Landingfoot spread (LFS, cm) in mice intoxicated with acrylamide. Mice were injected with actylamide from day 0 to 7 (total dose; 400 mglkg), and then allowed to recover from day 8 to 50. The number of mice examined by LFS was eight except for day 50 when five mice were examined. Regression lines were drawn with a linear regression analysis, separating the experimental period into days 0-8 (Y = 0-18X + 2-67, r = 0-79, P < 0 0001) and days 8-50 (Y =-0-04X+ 3-87, r = -077, P < 00001). Experimental day natants without nuclei were used to measure the activities of CK, glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1 2 1*12) and lactate dehydrogenase (LDH, EC 1-1-1 27), and the soluble fractions were used for CK, GAPDH, enolase (EC 4-2 1 11), and neuron specific enolase (NSE). Activities of GAPDH, enolase, and NSE were measured by the method of Howland et al. 5 When NSE activity was measured, the thermolabile non-neuronal enolase was inactivated at 50'C for 60 minutes." The CK and LDH activities were measured as described previously.6 Protein was measured by the method of Lowry et al. 12 
SECOND EXPERIMENT
To obtain enough blood to measure the activities of plasma enzymes, rats were used in this experiment. Male Wistar rats weighing 220-260 g were obtained from Kyudo (Kumamoto, Japan). Either acrylamide or isotonic saline was given to the rats, with the same procedure, in the first experiment except for the volume of solutions injected (0 33 ml/100 g/day). Twenty four hours after the last injection (total dose; 400 mg/kg), the animals were anaesthetised with diethyl ether, and blood was collected by cardiac puncture into the heparinised tube. The activities of plasma aspartate aminotransferase, alanine Activities of enzymes are expressed in terms of~umol/min/mg protein. 8 . The activities did not differ from the controls after day 23. Although the number of mice in each day was less than six, the present results agree well with our previous findings in which CK activities in the rat brain were suppressed by acrylamide.67
ACTIVITIES OF PLASMA ENZYMES IN RATS
A significant difference (P < 0-0001) in the increase of body weight during the experimental period (eight days) was found between the controls (47 (8) g, n = 12) and acrylamide group (22 (9) g, n = 13). On day 6 or 7, the acrylamide group developed ataxia and weakness of the hind limbs. There was a significant difference (P < 0 0005) in the LFS on day 8 between the controls (62 (20) mm, n = 9) and acrylamide group (110 (11) mm, n = 10).
Among the plasma enzymes examined on day 8, CK activity was most notably suppressed (table 3) . The activities of CK, alkaline phosphatase, and cholinesterase were lowered by 37%, 16%, and 12%, respectively. No alterations were found in the concentrations of tri-iodothyronine and thyroxine.
Discussion
The LFS was originally devised to evaluate neurological deficits caused by acrylamide in rats.'0 The method is simple and yet sensitive and quantitative when the neurological abnormalities are not too severe.'0 Although the significant suppression of the gain in body weight, an apparent sign of systemic intoxication, was found only in rats, LFS was obvious in both rats and mice, and we could measure the neurological dysfunction during and after acrylamide exposure.
In the mouse brain, GAPDH and NSE activities which had been reported to be inhibited by acrylamide in cats or rats,3 showed no significant changes throughout the experimental period over 51 days. Although the exact cause of the discrepancy between those studies3-5 and the present one is not clear, it may be due to species difference. Thus, GAPDH and NSE activities may not be so sensitive to acrylamide in mice as in cats or rats, although clinical signs of neurotoxicity of acrylamide were found in all of these species. This suggests that inhibition of GAPDH and NSE is not important in the genesis of neurotoxicity of acrylamide.
In contrast, activity of CK in the brain was clearly suppressed by acrylamide both in rats6 7 and in mice, as shown in the present study. Moreover, its suppression was most notable on day 8 when the neurological dysfunction measured by LFS was most severe. Also, as the neurological dysfunction became less apparent after the end of giving acrylamide, the suppression of activities of CK in the brain became less obvious until it returned to normal when there was no neurological dysfunction. Thus, inhibition of brain CK seems to be the most sensitive indicator of acrylamide intoxication among the enzymes so far examined.
With the non-invasive nuclear magnetic resonance (NMR) technique of magnetisation transfer, linear relations were found between the rate constant of the brain CK forward reaction (phosphocreatine + ADP --ATP + creatine) and the intensity of electroencephalograms in rats when general brain suppressant (thiopentone sodium) or stimulant (bicuculline) was given." This indicates that activity of CK is closely linked to the brain function. Considering this and the importance of substrates catalysed by CK, the inhibition of activity of CK in the brain might underlie the genesis of the neurotoxicity of acrylamide, especially that of encephalopathy, and it may be a good indicator of acrylamide intoxication. It should be noted that activities of CK in the brain could be measured in living animals by NMR."3 When this non-invasive technique becomes available to humans, the present results might provide reference data.
In the plasma of rats intoxicated with acrylamide, several enzymatic activities were decreased. Those may reflect the systemic effects of acrylamide. However, activity of GK was more suppressed than other activities. Moreover, CK activity was suppressed more; than NSE activity (and only CK was inhibited in the mouse brain by acrylamide). It is well known that activity of CK in the blood is affected by thyroid status; the activity decreases in hyperthyroidism and increases in hypothyroidism. Nevertheless, involvement of thyroid function in acrylamide intoxication was unlikely, as the levels of tri-iodothyronine and thyroxine were not changed.
Ethylene oxide, another neurotoxin which can cause encephalopathy and centralperipheral distal axonopathy as acrylamide can, also suppressed CK activity in the blood as well as in the brain.14 Thus, plasma CK activity may be used as a peripheral marker of intoxication with these neurotoxic chemicals. Obviously, more studies are necessary before CK activities are used to monitor human exposure to those neurotoxins.
